Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remimazolam and Emergence Delirium in Pediatrics — Stella

Home/Pediatric/Remimazolam and Emergence Delirium in Pediatrics

View on ClinicalTrials.gov

Recruiting

Back to Pediatric trials

Remimazolam and Emergence Delirium in Pediatrics

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

China

Peking University First Hospital, Beijing, Beijing Municipality

Peking University First Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Peking University First Hospital

Enrollment target

~248 participants

Started

January 2025

Primary completion

January 2027

Age range

1 Year – 6 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.